Mereo BioPharma (MREO) Payables (2020 - 2025)
Historic Payables for Mereo BioPharma (MREO) over the last 6 years, with Q3 2025 value amounting to $879000.0.
- Mereo BioPharma's Payables fell 8795.73% to $879000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $879000.0, marking a year-over-year decrease of 8795.73%. This contributed to the annual value of $8.0 million for FY2024, which is 23994.03% up from last year.
- According to the latest figures from Q3 2025, Mereo BioPharma's Payables is $879000.0, which was down 8795.73% from $1.1 million recorded in Q2 2025.
- Over the past 5 years, Mereo BioPharma's Payables peaked at $16.8 million during Q4 2022, and registered a low of $879000.0 during Q3 2025.
- For the 5-year period, Mereo BioPharma's Payables averaged around $5.3 million, with its median value being $3.5 million (2021).
- Per our database at Business Quant, Mereo BioPharma's Payables surged by 39924.62% in 2022 and then plummeted by 8795.73% in 2025.
- Mereo BioPharma's Payables (Quarter) stood at $3.4 million in 2021, then soared by 399.25% to $16.8 million in 2022, then plummeted by 86.05% to $2.3 million in 2023, then skyrocketed by 239.94% to $8.0 million in 2024, then tumbled by 88.98% to $879000.0 in 2025.
- Its last three reported values are $879000.0 in Q3 2025, $1.1 million for Q2 2025, and $2.9 million during Q1 2025.